RhumbLine Advisers’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-47,196
| Closed | -$69K | – | 3131 |
|
|
2016
Q1 | $69K | Buy |
47,196
+200
| +0.4% | +$292 | ﹤0.01% | 2940 |
|
|
2015
Q4 | $150K | Buy |
46,996
+4,190
| +10% | +$13.4K | ﹤0.01% | 2879 |
|
|
2015
Q3 | $268K | Buy |
42,806
+921
| +2% | +$5.77K | ﹤0.01% | 2624 |
|
|
2015
Q2 | $416K | Buy |
41,885
+4,190
| +11% | +$41.6K | ﹤0.01% | 2454 |
|
|
2015
Q1 | $278K | Buy |
37,695
+7,950
| +27% | +$58.6K | ﹤0.01% | 2655 |
|
|
2014
Q4 | $159K | Buy |
29,745
+1,025
| +4% | +$5.48K | ﹤0.01% | 2871 |
|
|
2014
Q3 | $144K | Buy |
28,720
+100
| +0.3% | +$501 | ﹤0.01% | 2865 |
|
|
2014
Q2 | $192K | Buy |
+28,620
| New | +$192K | ﹤0.01% | 2856 |
|